AVAC: Global Advocacy for HIV Prevention - Advocates' Network Update
 

September 1, 2011

Dear Advocates,

We are delighted to announce the inaugural issue of P-Values, AVAC's new bulletin highlighting advocacy work by our partners and many other stakeholders in the world of HIV prevention. This is an opt-in newsletter: if you’d like to stay abreast of advocacy work at a country and community level you can subscribe here. You’ll always be able to sign up on our website as well as look at past issues.

Click here to read the first issue of P-Values.

We’ve designed P-Values to give a flavor of the context-specific activities that advocates undertake every day to ensure that policy makers, programs and civil society are acting on the science and taking on the challenge to end the AIDS epidemic in our lifetime.

The term "p-value" refers to the probability that a trial result is a real finding and not coincidence. As the world faces new challenges and opportunities in HIV prevention, the global advocacy community isn't leaving anything to chance. P-Values tracks work on country- and community-level engagement in trials, preparing for results and the implementation of new findings.

Each issue will be concise and to the point. Highlights from our first issue include:

  • AVAC welcomes new members to PxROAR, our US domestic advocacy leadership program
  • Advocates use findings from Making Medical Male Circumcision Work for Women to advocate around important gender issues related to MMC rollout in Kenya
  • NHVMAS introduces new tools for lay people serving on Institutional Review Boards
  • Epicentro, IRMA and AVAC work to expand the HIV prevention research advocacy community in Latin America

P-Values will appear every month and go only to subscribers. The Advocates’ Network will continue to be our go-to source for updates on breaking news, trial results, “round ups” on specific prevention strategies and many other updates. The Weekly NewsDigest continues to provide an unedited compilation recapping the latest media coverage and scientific literature on HIV prevention.

To sign up to receive P-Values, or our other electronic publications, visit here. If you have any questions or comments, don't hesitate to contact us at avac@avac.org.

Best,
AVAC

Advocacy to accelerate ethical research and global delivery of AIDS vaccines and other HIV prevention options
Follow AVAC Facebook  Twitter
423 West 127th St
4th Floor
New York, NY 10027
USA
T   +1 212 796 6423
F   +1 646 365 3452
E   avac@avac.org
W   www.avac.org
This email was sent to [EMAIL]. To ensure that you continue receiving our emails, please add us to your address book or safe list.

Got this as a forward? Sign up to receive our future emails.
If you would like to unsubscribe, email us.